Header cover image
  • Investing Ideas
  • /
  • Norwegian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Norwegian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

1

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

1 companies

Vistin Pharma

Market Cap: NOK 1.1b

Through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 24.00

7D

2.6%

1Y

-0.4%